Browse more on » Medical/Pharmaceuticals, Awards

Ajanta Pharma gets UK MHRA Approval

Ajanta Pharma Limited, a specialty focused pharmaceutical formulation company, has received approval from MHRA of United Kingdom (UK) for its formulation manufacturing facility at Paithan, Aurangabad, India

Mumbai, Maharashtra, August 24, 2011 /India PRwire/ -- Ajanta Pharma Limited, a specialty focused pharmaceutical formulation company, has received approval from Medicines & Healthcare products Regulatory Agency (MHRA) of United Kingdom (UK) for its formulation manufacturing facility at Paithan, Aurangabad, India. Mr. Yogesh Agrawal, Managing Director described the facility approval as "significant milestone, paving the way for entry to the European Union market".

Ajanta Pharma's Paithan manufacturing facility is already approved by US FDA and has by now obtained the approval for one ANDA. Another ANDA is under approval and number of other ANDA's are in process of filing. Besides USA and UK, world's two most stringent regulatory approvals, Ajanta's Paithan facility also holds the WHO Pre-qualification approval from WHO Geneva.

Commenting on the development, Mr. Yogesh Agrawal, Managing Director said. "We continue to build expertise in the quality standards and approvals from the most stringent regulatory authorities like USA, UK and WHO Pre-qualification are testimony to our commitment towards quality. The foundation being laid down now shall assure sustained growth for the company in years to come"

Notes to Editor

Ajanta Pharma is a specialty branded fully integrated pharmaceutical formulation company, having leading brands in therapeutic segments of Ophthalmology, Dermatology and Cardiology. Many of company's products are first of its kind and are leading in their sub therapeutic segments. Company exports its products to more than 25 countries and established strong brand equity in these markets.

Ajanta Pharma has its State of the Art R&D centre at Kandivali Mumbai, with more than 200 scientists working for formulation development. Company has world class manufacturing facilities - 4 located in India and 1 at Mauritius. For the year ending March 2011, company had the consolidated sales of Rs. 510crs. (USD 114million) and has been consistently posting healthy growth in sales and profitability for last decad


Journalists and Bloggers
Visit India PRwire for Journalists for releases, photos, email alerts and customized feeds just for Media.

If you have any query regarding information in the press releases, please contact the company listed in the press release itself. Please do not call India PRwire, we will be unable to assist you with your inquiry.


Ajanta Pharma Limited recent press release(s)


Ajanta Pharma gets into Top 50 league in the country Consolidated Net up 52%, Posts 36% growth in Consolidated Revenue

Ajanta Pharma Limited, a specialty focused pharmaceutical formulation company, has entered in Top 50 companies in the country in the domestic market as per IMS ranking for March 2012. Company has posted 52% growth in Consolidated Net Profit for the financial year 2011-12, with Consolidated Profit after Tax at Rs.77.27crs (Rs.50.71crs). The Consolidated revenue was up 36% a...

Ajanta Pharma Achieves Excellent Growth Q3 Profit After Tax up 55%

Ajanta Pharma Limited, a specialty focused pharmaceutical formulation company, has posted 55% increase in net profit for the third quarter of FY 2011-12. The Profit after Tax stood at Rs. 18.51crores (Rs.11.95crores) for the quarter ended December 31, 2011. Net sales for the quarter stood at Rs. 163.90crores (Rs.120.51crores), an excellent growth of 36% over same period of...

Ajanta Pharma Continues Growth

Ajanta Pharma Limited, a specialty focused pharmaceutical formulation company, has posted 18% increase in net profit for the second quarter of FY 2011-12. The Profit after Tax stood at Rs.11.85crores (Rs.10.05crores) for the quarter ended September 30, 2011. Net sales for the quarter stood at Rs.135.13crores (Rs.112.51crores), an excellent growth of 20% over same period of...

Ajanta Pharma Net Profit up 80%

Ajanta Pharma Limited, a specialty focused pharmaceutical formulation company, has posted 80% increase in net profit for the first quarter of FY 2011-12. The Profit after Tax stood at Rs.12.53crores (Rs.6.98crores) for the quarter ended June 30, 2011. Net sales for the quarter ended June 30, 2011 stood at Rs.127.31crores (Rs.98.29crores), an excellent growth of 30% over sa...

Ajanta Pharma Signs Agreement with Dabur

30-Plus is one of the oldest and strongest health care energizer brands in the country. However, with the change in focus at Ajanta Pharma, the OTC brand was stagnant for some time, though it still enjoys a strong recall as an energiser brand.